Modified siRNAs for the study of the PAZ  domain by Somoza, Álvaro et al.
PRIVILEGED DOCUMENT FOR REVIEW PURPOSES ONLY
1 
 
 
ELECTRONIC SUPPLEMENTARY INFORMATION (ESI). 
Modified siRNAs for the Study of the PAZ Domain 
 
Álvaro Somoza,*a Montserrat Terrazas,b,c Ramón Eritja*b,c 
 
a Instituto Madrileño de Estudios Avanzados en Nanociencia (IMDEA-Nanociencia), 
E-28049, Madrid, Spain. b Instituto de Química Avanzada de Cataluña-Consejo 
Superior de Investigaciones Científicas (IQAC-CSIC), E-08034, Barcelona, Spain. 
c Institut de Recerca Biomèdica, CIBER-BBN, C/ Baldiri Reixac 15, E-08028, 
Barcelona, Spain. 
 Correspondence should be addressed to: A.S. (alvaro.somoza@imdea.org) or R.E. 
(ramon.eritja@irbbarcelona.org).  
 
CONTENTS: 
GENERAL PROCEDURES                                                                                       2 
 General experimental methods 
 Procedure A: Amide Formation 
 Procedure B: DMTr Protection 
 Procedure C: CPG Functionalization 
 
CHARACTERIZATION OF ORGANIC COMPOUNDS                                             3 
RNA SYNTHESIS AND PURIFICATION METHODS                                                9 
OLIGONUCLEOTIDE CHARATERIZATION                                                           10 
THERMAL STABILITY OF SIRNAS                                                                        10 
STABILITY OF SIRNAS IN 50% HUMAN SERUM                                                 11 
RNA INTERFERENCE METHODS                                                                          12 
AUTODOCK-VINA DOCKING                                                                                 13 
NMR SPECTRA                                                                                                       14                
Supplementary Material (ESI) for Chemical Communications
This journal is (c) The Royal Society of Chemistry 2010
PRIVILEGED DOCUMENT FOR REVIEW PURPOSES ONLY
2 
 
 
General Procedures: 
 
General experimental methods: Reagents were purchased from Aldrich and used 
without further purification. Thin layer chromatography was carried out using Silica 
Gel 60 F254 plates. Column chromatography was performed using Silica Gel (60 Å, 
230 x 400 mesh). All NMR spectra were recorded on Varian Mercury 400 MHz 
(Unitat d'RMN, Serveis Cientificotècnics, Parc Cientific de Barcelona) instrument as 
solutions in the deuterated solvent indicated, and the chemical shifts are reported in 
parts per million (ppm). Coupling constants are reported in hertz (Hz). HRMS were 
performed on a LC/MSD-TOF  (Agilent technologies) high resolution mass 
spectrometer by Servei d’Espectrometria de Masses (Universitat de Barcelona). 
 
Procedure A: Amide Formation : 
 
To a solution of the corresponding acid (1.2 equiv) in DMF (0.5 M) at room 
temperature, N-hydroxybenzotriazole (1.1 equiv) and diisopropylcarbodiimide (1.1 
equiv) were added. After stirring the mixture for 5 minutes D- or L- Threoninol (1 
equiv) was added. The resulting mixture was stirred at room temperature for 24 h 
and then quenched by the addition of methanol. The solvent was evaporated under 
vacuum and the residue purified by flash chromatography.  
 
Procedure B: DMTr Protection: 
 
To a solution of the corresponding diol (1 equiv) in pyridine (0.2 M) at 0º C, 
diidopropylethylamine (1.5 equiv), 4,4´-dimethoxyltritylchloride (1.2 equiv) and 
dimethylaminopyridine (catalytic amount) were added. After 15 min the mixture was 
allowed to reach room temperature, then it was stirred for 24 h and finally the 
reaction was quenched with methanol The solvent was evaporated under vacuum 
and the residue purified by flash chromatography. 
 
Procedure C: CPG Functionalization (Two Steps):1 
I 
To a solution of the corresponding alcohol (1 equiv) in dichloromethane (0.2 M) 
succinic anhydride (1.3 equiv), diisopropylethylamine (1.4 equiv) and 
dimethyaminopyridine (catalytic amout) were added. The solution was stirred for 24 
h at room temperature. Then, the solution was washed with a solution of sodium 
dihydrogen phosphate (1%). The organic layer was dried over Magnesium sulfate, 
filtered and evaporated to yield a yellowish oil. 
II 
To a solution of DMAP (1.5 equiv) in acetonitrile (60 mM) the product obtained in 
step II was added (1 equiv). After mixing it well (vortex), the solution was added to a 
solution of 2,2´-dithiobis-(5-nitropyridine) (1.5 equiv). The solution was mixed well 
and added to triphenyl phosphine (1.5 equiv). The mixture was vortexed till all 
reagents were dissolved giving rise to a reddish solution, which was added to 200 
                                                 
1
   Gupta, K. C.; Kumar, P.; Bhatia, D.; Sharma, A. K. Nucleosides and Nucleotides, 1995, 14, 829-832. 
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mg of CPG (500 Ǻ). After 1 h at room temperature the solution was removed and 
the CPG washed with methanol (3 X 20 mL) and, dry acetonitrile (3 x 20 mL). Once 
the CPG was dry, 2 mL of a 1:1 mixture of the capping reagents utilized on 
oligonucleotide synthesis (Cap Mix A: Acetic anhydride/Py/THF; Cap Mix B: 1-
Methylimidazole /THF; from GlenResearch) was added. After 15 min at room 
temperature, the CPG was washed with dry acetontrile (6 x 20 mL) and dried. 
The CPG loading was calculated by detrytylation of a sample as follows: 10 mg of 
CPG were treated with 5 mL of a detrytilation solution (3mL of perchloric acid and 2 
mL of ethanol) for 30 min. Then 200 uL of the mixture were dissolved in 800 uL of 
the detrytilation solution and absorbance was measured at 498. Functionalization 
(F) was determined by Lambert-Beer law. F = (ABS x V) / (ε x  gr) = M/ gr. 
 
 
 
CHARACTERIZATION OF ORGANIC COMPOUNDS 
 
N-[(2S, 3R)-1,3-dihydroxybutan-2-yl]pyrene-1-carboxamide (1a). 
 
 
OH
OH
NH
O
OH
OH
O
OH
NH2
Diisopropylcarbodiimide
HOBt DMF
rt, 24 h
+
(79%)
(1a)  
 
 
Compound 1a was obtained following procedure A. After flash chromatography 
(cyclohexane 4 / CH2Cl2 4 / MeOH 0.5) 302 mg (0.906 mMol) were obtained as a 
white solid (79%).  1H NMR (400 MHz, CD3OD): 8.53 (d, J = 9.3 Hz, 1H), 8.25 (t, J = 
7.5 Hz, 3H), 8.21-8.02 (m, 5H), 4.28 (dt, J = 6.2 and 3.6 Hz, 1H), 4.18 (dq, J = 6.4 
and 3.6 Hz, 1H), 3.87 (System ABX, JAB= 11.1 Hz, JAX = 5.8 Hz, and JBx= 6.6 Hz, 
2H),      1.38 (d, J = 6.4 Hz, 3H). 13C NMR (100 MHz, CD3OD): 173.4, 133.9, 132.8, 
132.6, 132.1, 129.7, 129.6, 129.5, 128.3, 127.6, 126.9, 126.8, 126.1, 125.8, 125.61, 
125.59, 125.51, 67.5, 63.0, 58.5, 20.8. HRMS m/z: Calc for C21H20NO3 (M + H
+) 
334.1437, found 334.1449. 
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N-[(2S, 3R)-1-(bis(4-methoxyphenyl)(phenyl)methoxy)-3-hydroxybutan-2-yl)-
pyrene-1-carboxamide (1b). 
 
OH
OH
NH
O
DMTrCl
Py
DIPEA, DMAP
rt, 24h
(92%)
OH
ODMTr
NH
O
(1b)
(1a)
 
 
 
Compound 1b was obtained following procedure B. After flash chromatography 
(cyclohexane 2 / EtOAc 1) 133 mg (0.209 mMol) were obtained as a white solid and 
24 mg of the starting material were recovered.  (70% yield, or 92% yield based on 
the recovered starting material).  1H NMR (400 Mz, CDCl3): 8.62 (d, J = 9.3 Hz, 1H), 
8.21 (d, J = 7.7 Hz, 2H), 8.12 (s, 3H), 8.09 (d, J = 2.1 Hz, 1H), 8.04 (t, J = 7.7 Hz, 
2H), 7.45 (d, J = 7.6 Hz, 2H), 7.34 (d, J = 8.7 Hz, 4H), 7.28 (t, J = 7.7 Hz, 2H), 7.20 
(t, J = 7.2 Hz, 1H), 6.89 (d, J = 8.7 Hz, 1H), 6.81 (dd, J = 8.9 and 2.8 Hz, 4H), 4.38-
4.32 (m, 1H), 4.28-4.22 (m, 1H), 3.73 (s, 3H), 3.72 (s, 3H), 3.63 (ABX System, JAB = 
9.6 Hz, JAX = 3.7 Hz, JBX = 3.6 Hz, 2H), 1.35 (d, J = 6.3 Hz, 3H). 
13C NMR (100 
MHz, CDCl3): 170.2, 158.6, 158.5, 144.3, 135.4, 135.2, 132.6, 131.1, 130.7, 130.6, 
129.9 (4C), 128.7, 128.6, 128.5, 128.0 (2C), 127.9 (2C), 127.0, 126.9, 126.3, 125.8, 
125.7, 124.7, 124.5, 124.5, 124.3, 124.2, 113.3 (4C), 86.9, 69.0, 65.6, 55.1 (2C), 
54.3, 20.3. HRMS m/z: Calc for C42H37NO5Na (M + Na
+) 658.2563, found 658.2563. 
 
 
N-[(2S, 3R)-1,3-dihydroxybutan-2-yl)anthracene-9-carboxamide (2a). 
 
OH
OH
NH
O
OH
OH
O
OH
NH2
Diisopropylcarbodiimide
HOBt DMF
rt, 24 h
+
(49%) (2a)  
 
Compound 2a was obtained following procedure A. After flash chromatography 
(cyclohexane 6 / CH2Cl2 3 / MeOH 0.5) 273 mg (1.052 mMol) were obtained as a 
yellowish solid (49%). 1H NMR (400 MHz, CD3OD): 8.56 (s, 1H), 8.27-8.15 (m, 2H), 
8.06 (d, J = 8.3 Hz, 2H), 7.57-7.47 (m, 4H), 4.40 (ddd, J = 6.7, 5.6 and 3.9 Hz, 1H), 
4.15 (dq, J = 6.4 and 3.8 Hz, 1H), 3.87 (ABX System: JAB = 11.0 Hz, JAX = 5.6 Hz, 
JBX = 6.9 Hz, 2H), 3.35 (s, 1H), 1.39 (d, J = 6.4 Hz, 3H). 
13C NMR (100 MHz, 
D3OD): 172.7, 133.5, 132.7, 129.6 (2C), 129.3, 129.2 (2C), 127.7 (2C), 126.6 (4C), 
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126.4, 67.4, 63.0, 58.8, 20.9. HRMS m/z: Calc for C19H19NNaO3 (M + Na)
+ 
332.1257, found 332.1258. 
 
N-[(2S, 3R)-1-(bis(4-methoxyphenyl)(phenyl)methoxy)-3-hydroxybutan-2-yl]-
anthracene-9-carboxamide (2b). 
 
OH
OH
NH
O
DMTrCl
Py
DIPEA, DMAP
rt, 24h
OH
ODMTr
NH
O
(62%)
(2a) (2b)
 
 
Compound 2b was obtained following procedure B. After flash chromatography 
(cyclohexane 3 / EtOAc 1) 130 mg (0.213 mMol) were obtained as a white solid 
(62%). 1H NMR (400 Mz, CDCl3): 8.48 (s, 1H), 8.11 (bs, 1H), 8.01 (d, J = 9.2 Hz, 
2H), 7.47 (t, J = 8.2 Hz, 2H), 7.41 (d, J = 7.2 Hz, 2H), 7.31 (d, J = 8.8 Hz, 4H),  7.26 
(t, J = 7.4 Hz, 2H), 7.21 (d, J= 7.0 Hz, 1H), 6.80 (d, J = 8.8 Hz, 4H), 6.73 (d, J = 8.8 
Hz, 1H), 4.49 (td, J = 7.3 and 3.9 Hz, 1H), 4.16 (m, 1H), 3.77 (s, 3H), 3.76 (s, 3H), 
3.62 (ABX System, JAB = 9.6 Hz, JAX = 3.6 Hz, JBX = 4.4 Hz, 2H),  3.07 (s, 1H), 1.35 
(d, J = 6.3 Hz, 3H). 13C NMR (100 MHz, CDCl3): 169.9, 158.6 (2C), 144.2 (2C), 
135.4, 135.1, 131.7, 131.1 (2C), 130.0 (3C), 129.9 (3C), 128.5 (2C), 128.3, 128.1, 
128.0 (2C), 127.9 (2C), 127.0, 126.7 (2C), 125.4, 125.2, 113.3 (2C), 113.2 (2C), 
86.9, 68.8, 65.5, 55.2 (2C), 54.6, 20.6. HRMS m/z: Calc for C40H37NNaO5 (M + Na)
+ 
634.2564, found 634.2570. 
 
N-[(2S, 3R)-1,3-dihydroxybutan-2-yl]-1-naphthamide (3a). 
 
OH
OH
NH
O
OH
OH
O
OH
NH2
Diisopropylcarbodiimide
HOBt DMF
rt, 24 h
+
(92%)
(3a)  
 
 
Compound 3a was obtained following procedure A. After flash chromatography 
(cyclohexane 6 / CH2Cl2 3 / MeOH 0.5) 273 mg (1.052 mMol) were obtained as a 
yellowish solid (92%). 1H NMR (400 MHz, CD3OD): 8.26 (d, J = 9.1 Hz, 1H), 7.95 
(d, J = 8.3 Hz, 1H),  7.90 (d, J = 7.3 Hz, 1H), 7.69 (d, J = 7.0 Hz, 1H), 7.57-7.47 (m, 
3H), 4.21-4.16 (m, 1H), 4.15-4.09 (m, 1H), 3.79 (System ABX; JAB = 11.1 Hz, JAX = 
5.8 Hz, JBX = 6.5 Hz, 2H), 1.30 (d, J = 6.4 Hz, 3H). 
13C NMR (100 MHz, CD3OD): 
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173.1, 136.1, 135.3, 131.7, 131.6, 129.6, 128.2, 127.6, 126.6, 126.5, 126.1, 67.6, 
63.1, 58.4, 20.9. HRMS m/z: Calc for C15H18NO3 (M + H
+) 260.1281, found 
260.1291. 
 
N-[(2S, 3R)-1-(bis(4-methoxyphenyl)(phenyl)methoxy)-3-hydroxybutan-2-yl]- 1-
naphthamide (3b). 
 
OH
OH
NH
O
DMTrCl
Py
DIPEA, DMAP
rt, 24h
OH
ODMTr
NH
O
(31%)
(3a) (3b)
 
 
Compound 3b was obtained following procedure B. After flash chromatography 
(cyclohexane 3 / EtOAc 1) 146 mg (0.259 mMol) were obtained as a white solid 
(31%). 1H NMR (400 Mz, CDCl3): 8.37-8.32 (m, 1H), 7.95 (d, J = 8.2 Hz, 1H), 7.92-
7.87 (m, 1H), 7.66 (dd, J = 7.0 and 1.1 Hz, 1H), 7.56-7.52 (m, 2H), 7.48 (dd, J = 8.2 
and 7.1 Hz, 1H), 7.40 (d, J = 7.2 Hz, 2H), 7.31 (d, J = 8.9 Hz, 4H), 7.26 (t, J = 7.3 
Hz, 2H), 7.20 (t, J = 7.1 Hz, 1H), 6.80 (dd, J = 8.8 and 3.7 Hz, 4H), 6.71 (d, J = 8.8 
Hz, 1H), 4.28-4.24 (m, 1H), 4.23-4.18 (m, 1H), 3.76 (s, 3H), 3.75 (s, 3H), 3.56 
(System ABX, JAB = 9.7 Hz, JAX = 3.8 Hz, JBX = 3.6 Hz, 2H), 3.17 (s, 1H), 1.29 (d, J 
= 6.34 Hz, 3H). 13C NMR (100 MHz, CDCl3): 169.8, 158.7, 158.6, 144.2, 135.4, 
135.2, 134.4, 133.7, 130.7, 130.1, 129.9 (4C), 128.3, 128.0 (2C), 127.9 (2C), 127.2, 
127.0, 126.4, 125.5, 124. 9, 124.7, 113,3 (4C), 86.9, 69.1, 65.7, 55.2 (2C), 53.9, 
20.2. HRMS m/z: Calc for C36H35NNaO5 (M + Na)
+ 584.2407, found 584.2402. 
 
N-[(2S, 3R)-1,3-dihydroxybutan-2-yl)-4-(trifluoromethyl]benzamide (4a). 
 
OH
OH
NH
O
OH
OH
O
OH
NH2
Diisopropylcarbodiimide
HOBt DMF
rt, 24 h
+
F
F
F
F
F
F
(60%)
(4a)  
Compound 4a was obtained following procedure A. After flash chromatography 
(cyclohexane 4 / CH2Cl2 4/ MeOH 0.5) 157 mg (0.566mMol) were obtained as a 
white solid (60%). 1H NMR (400 MHz, CD3OD): 8.03 (d, J = 8.2 Hz, 2H), 7.78 (d, J = 
8.2 Hz, 2H), 4.14-4.04 (m, 2H), 3.75 (System ABX: JAB = 11.2 Hz, JAX = 5.6 Hz, JBX 
= 6.2 Hz, 2H), 1.22 (d, J = 6.2 Hz, 3H). 13C NMR (100 MHz, CD3OD): 169.4, 139.7, 
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134.1 (q, JF-C = 32.4 Hz, 1C), 129.3 (2C), 126.5 (q, JF-C = 3.8 Hz, 2C), 124.0, 67.3, 
62.8, 58.4, 20.6. 19F NMR (376 MHz, CD3OD): -64.86. HRMS m/z: Calc for 
C12H15NO5F3 (M + H
+) 278.0998, found 278.0999. 
 
N-[(2S, 3R)-1-(bis(4-methoxyphenyl)(phenyl)methoxy)-3-hydroxybutan-2-yl]-4-
(trifluoromethyl)benzamide (4b). 
 
OH
OH
NH
O
DMTrCl
DIPEA, DMAP
Pyridine
rt, 24 h
OH
ODMTr
NH
O
F
F
F
F
F
F
(77%)
(4a) (4b)
 
Compound 4b was obtained following procedure B. After flash chromatography 
(cyclohexane 3 / EtOAc 1) 580 mg (0.828 mMol) were obtained as a white solid 
(77%). 1H NMR (400 Mz, CDCl3): 7.89 (d, J = 8.1 Hz, 2H), 7.73 (d, J = 8.2 Hz, 2H), 
7.38 (d, J = 7.2 Hz, 2H), 7.30-7.18 (m, 4H), 6.79 (dd, J = 8.8 and 6.8 Hz, 2H), 4.28-
4.20 (m, 1H), 4.15-4.10 (m, 1H), 3.76 (s, 3H), 3.75 (s, 3H), 3.49 (System ABX: JAB = 
9.8 Hz, JAX = 4.2 Hz, JBX = 3.4 Hz, 2H),  3.07 (s, 1H), 1.21 (d, J = 6.4 Hz, 3H). 
13C 
NMR (100 MHz, CDCl3): 166.3, 158.6 (2C), 144.2, 137.6, 135.3, 135.2, 133.3 (q, JF-
C = 32.8 Hz, 1C),  129.9 (2C), 129.8 (2C), 128.0 (2C), 127.8 (2C), 127.4 (2C), 
127.0, 125.7 (q, JF-C = 3.8 Hz, 2C), 124.9, 113.3 (2C), 113.2 (2C), 86.9, 68.5, 65.2, 
55.1(2C), 54.0, 20.1. 19F NMR (376 MHz, CDCl3): -63.36. HRMS m/z: Calc for 
C33H32F3NNaO5 (M + Na)
+ 602.2125, found 602.2126. 
 
N-[(2S, 3R)-1,3-dihydroxybutan-2-yl]-4-fluorobenzamide (5a). 
 
OH
OH
NH
O
F
OH
OH
O
F
OH
NH2
Diisopropylcarbodiimide
HOBt DMF
rt, 24 h
+
(69%)
(5a)
 
Compound 5a was obtained following procedure A. After flash chromatography 
(cyclohexane 5 / CH2Cl2 4 / MeOH 0.5) 180 mg (0.792 mMol) were obtainded as a 
white solid (69%). 1H NMR (400 MHz, CD3OD): 7.92 (dd, J = 8.8 and 5.4 Hz, 2H), 
7.20 (t, J = 8.7 Hz, 2H), 4.13-4.02 (m, 2H), 3.73 (System ABX, JAB = 11.2 Hz, JAX = 
5.9 Hz, JBX = 6.3 Hz, 2H), 1.21 (d, J = 6.4 Hz, 3H). 
13C NMR (100 MHz, CD3OD): 
169.5, 166.2 (d, JF-C = 250.5 Hz, 1C) , 132.1, 131.0 (d, JF-C = 8.9 Hz, 2C), 116.4 (d, 
JF-C = 22.1Hz, 2C), 67.3, 62.8, 58.2, 20.6. 
19F NMR (376 MHz, CD3OD): -111.2. 
HRMS m/z: Calc for C11H15NO3F (M + H
+) 228.1030, found 228.1035. 
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N-[(2S, 3R)-1-(bis(4-methoxyphenyl)(phenyl)methoxy)-3-hydroxybutan-2-yl]-4-
fluorobenzamide (5b). 
 
 
OH
OH
NH
O
F
DMTrCl
DIPEA, DMAP
Pyridine
rt, 24 h
OH
ODMTr
NH
O
F
(45%)
(5a) (5b)
 
 
Compound 5b was obtained following procedure B. After flash chromatography 
(cyclohexane 3 / EtOAc 1) 313 mg (0.591 mMol) were obtained as a white solid 
(45%). 1H NMR (400 Mz, CDCl3): 7.81 (dd, J = 8.8 and 5.3 Hz, 2H), 7.37 (d, J = 7.1 
Hz, 2H), 7.30-7.18 (m, 7H), 7.14 (t, J = 8.6 Hz, 2H), 6.79 (dd, J = 8.9 and 6.8 Hz, 
4H), 4.21 (d, J = 6.3 Hz, 1H), 4.15-4.05 (m, 1H), 3.77 (s, 3H), 3.76 (s, 3H), 3.56 (dd, 
J = 9.7 and 4.2 Hz, 1H), 3.38 (dd, J = 9.7 and 3.4 Hz, 1H), 3.13 (s, 1H), 1.20 (d, J = 
6.37 Hz, 3H). 13C NMR (100 MHz, CDCl3): 166.6, 164 (d, JF-C = 252 Hz, 1C), 158.6 
(2C), 144.2, 135.4, 135.2, 130.5 (d, JF-C = 3.2 Hz, 1C), 129.9 (2C), 129.8 (2C), 
129.3 (d, JF-C = 8.9 Hz, 2C), 128.0 (2C), 127.8 (2C), 127.0, 115.6 (d, JF-C = 21.8 Hz, 
2C), 113.3 (4C), 86.9, 68.9, 65.5, 55.2 (2C), 53.9, 20.0. 19F NMR (376 MHz, CDCl3): 
-108.44. HRMS m/z: Calc for C32H32NO5FNa (M + Na
+) 552.2156, found 552.2143. 
 
N-[(2S, 3R)-1,3-dihydroxybutan-2-yl]-acetamide (6a). 
 
OH
OH
NH
O
OH
OH O
OH
NH2
Diisopropylcarbodiimide
HOBt DMF
rt, 24 h
+
(76%) (6a)  
 
Compound 6a was obtained following procedure A. After flash chromatography 
(cyclohexane 4 / CH2Cl2 4 / MeOH 0.5) 159 mg (1.08 mMol) were obtained as a 
colorless oil (76%). 1H NMR (400 MHz, CD3OD): 4.04-3.94 (m, 1H), 3.84-3.76 (m, 
1H), 3.61 (System ABX, JAB = 11.0 Hz, JAX = 5.9 Hz, JBX = 6.3 Hz, 2H), 2.00 (s, 3H), 
1.14 (d, J = 6.4 Hz, 3H). 13C NMR (100 MHz, CD3OD): 173.8, 67.2, 62.8, 57.6, 22.7, 
20.4. HRMS m/z: Calc for C6H11NO2 (M – H2O) 129.0790, found 129.1524. 
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N-[(2S, 3R)-1-(bis(4-methoxyphenyl)(phenyl)methoxy)-3-hydroxybutan-2-yl]-
acetamide (6b). 
 
OH
OH
NH
O
DMTrCl
DIPEA, DMAP
Pyridine rt, 24 h
OH
ODMTr
NH
O
(27%)
(6b)
 
Compound 6b was obtained following procedure B. After flash chromatography 
(cyclohexane 1 / EtOAc 3)  85 mg (0.189 mMol) were obtained as a yellowish solid. 
1H NMR (400 Mz, CDCl3): 7.38 (d, J = 7.3 Hz, 2H), 7.27 (d, J = 8.8 Hz, 6H), 7.22 (t, 
J = 7.2 Hz, 1H), 6.83 (d, J = 8.74 Hz, 4H), 6.05 (d, J = 8.7 Hz, 1H), 4.15-4.06 (m, 
1H), 3.94-3.88 (m, 1H), 3.79 (s, 6H), 3.35 (System ABX, JAB = 9.7 Hz, JAX = 4.4 Hz, 
JBX = 3.5 Hz, 2H), 3.02 (s, 1H), 2.02 (s, 3H), 1.13 (d, J = 6.4 Hz, 3H). 
13C NMR (100 
MHz, CDCl3): 170.4, 158.7 (2C), 144.3, 135.5, 135.3, 129.9 (2C), 129.8 (2C), 128.0 
(2C), 127.9 (2C), 127.0, 113.3 (4C), 86.9, 68.7, 65.4, 55.2 (2C), 53.4, 23.3, 19.9. 
HRMS m/z: Calc for C27H31NNaO5 (M + Na)
+ 472.2100, found: 472.2096. 
 
RNA synthesis and purification methods: 
 
 RNA oligonucleotides were synthesized in a ABI 394 DNA / RNA Synthesizer using 
2’-TBDMS phosphoramidites (Sigma-Aldrich). RNA oligonucleotides were 
synthesized on the 1 μmol scale. After solid-phase synthesis, the solid support was 
transferred to a screw-cap glass vial and incubated at 55 ºC for 1 h with 1.5 mL of 
NH3 solution (33%) and 0.5 mL of ethanol. After the vial was cooled briefly on ice, 
the supernatant was transferred by pipet into 2 mL Eppendorf tubes; the solid 
support and vial were rinsed with 50% ethanol (2 × 0.25 mL). The combined 
solutions were evaporated to dryness using an evaporating centrifuge. The residue 
was dissolved in a total volume of 0.33 mL of TBAF (1M) in THF and rocked at 
room temperature for 12 h. Then, 0.33 mL of Et3NHAcO (1 M) and 0.33 mL of water 
were added to the solution, and the oligonucleotide was desalted on a NAP-10 
column using water as the eluent and evaporated to dryness. The oligonucleotides 
were purified by HPLC (DMT-ON). The pure fractions were combined and 
evaporated to dryness. The residues were treated with 0.4 mL of AcOH solution 
(3%) and incubated at room temperature for 1 h. The deprotected oligonucleotides 
were purified by HPLC (DMT-OFF).  The pure fractions were combined and 
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evaporated to reach a volume of 0.5 mL and desalted using a NAP-5 column and 
water as eluent.  
 
Oligonucleotide Charaterization. 
 
 
All synthesized oligonucleotides were characterized by MALDI-TOF mass 
spectrometry: 
 
Oligonucleotide Sequence MW 
calculated 
MW 
found 
WT GS 5-UCGAAGUAUUCCGCGUACGTT-3’ 6646.2 6646.2 
Py GS 5-UCGAAGUAUUCCGCGUACGT-Py-3’ 6736.1 6731.1 
Anthra GS 5-UCGAAGUAUUCCGCGUACGT-Antra-3’ 6712.1 6707.8 
Naph GS 5-UCGAAGUAUUCCGCGUACGT-Naph-3’ 6662.1 6657.4 
CF3 GS 5-UCGAAGUAUUCCGCGUACGT-CF3-3’ 6680.1 6673.3 
F GS 5-UCGAAGUAUUCCGCGUACGT-F-3’ 6630.1 6625.6 
Me GS 5-UCGAAGUAUUCCGCGUACGT-Me-3’ 6550,1 6550.9 
WT PS 5’-CGUACGCGGAAUACUUCGATT-3’ 6669.2 6669.4 
Py PS 5’-CGUACGCGGAAUACUUCGAT-Py-3’ 6759.1 6753.5 
Anthra PS 5’-CGUACGCGGAAUACUUCGAT-Antra-3’ 6735,1 6735.3 
Naph PS 5’-CGUACGCGGAAUACUUCGAT-Naph-3’ 6685,1 6686.4 
CF3 PS 5’-CGUACGCGGAAUACUUCGAT-CF3-3’ 6703.1 6707.4 
F PS 5’-CGUACGCGGAAUACUUCGAT-F-3’ 6653,1 6656.6 
Me PS 5’-CGUACGCGGAAUACUUCGAT-Me-3’ 6573.1 6576.9 
 
GS: Guide Strand; PS: Passenger Strand. 
 
 
Thermal Stability of siRNAs 
 
For annealing of siRNAs, a solution of guide and passenger strand at 20M in 
annealing buffer (100mM potassium acetate, 30mM HEPES-KOH at pH 7.4, 2mM 
magnesium acetate) were incubated for 1 min at 92 ºC and cooled down slowly to 
room temperature. 
SiRNAs (0.5 μM each) were dissolved in buffer (50 mM potassium acetate, 1 mM 
magnesium acetate, 15 mM HEPES-KOH at pH 7.4). Experiments were performed 
in Teflon-stoppered 1 cm path length quartz cells on a JASCO V-650  
spectrophotometer equipped with thermoprogrammer. The denaturation 
experiments were done at a rate of 1 °C/min to 90 °C, monitoring absorbance at 
260 nm. In all cases the complexes displayed sharp, apparently two-state 
transitions. The data were analyzed by the denaturation curve processing program, 
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MeltWin v. 3.0. Melting temperatures (Tm) were determined by computer-fit of the 
first derivative of absorbance with respect to 1/T. 
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Stability of siRNAs in 50% human serum 
 
Unmodified or modified double-stranded siRNA samples (20 µM; 24 µL) were 
incubated in human serum (24 µL) at 37 ºC. At appropiate periods (0, 0.5, 1, 2, 4, 7 
and 9 hours), 6 µL aliquots of the reaction mixture were added to 54 µL of a 1% 
sodium dodecyl sulphate aqueous solution and the mixtures were heated-denatured 
for 5 min at 90 ºC. siRNAs were isolated by hot phenol extraction followed by 
ethanol precipitation. In the case of F and CF3 the hot phenol extraction was 
skipped due to problems with the extraction. After re-suspension in 20 µL of loading 
buffer (90% formamide, 10% 1X TBE), the samples were run on a denaturing 14% 
polyacrylamide gel containing 20% formamide. RNA bands were visualized with the 
SYBR Green II reagent (Sigma-Aldrich) according to the manufacturer’s 
instructions. 
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RNA interference methods 
 SH-SY5Y and Hela cells were grown at 37 ºC, 5% CO2 in Dulbecco’s modified 
Eagles’s medium (DMEM, GIBCO) supplemented with 10% fetal bovine serum 
(FBS), 100 U/mL penicillin and 100 μg/mL streptomycin. The cells were maintained 
in exponential growth. The cells were plated in 24-well plates (0.5 mL medium/well) 
to reach about 50% confluence at transfection. The cells were grown for 24 h and 
the culture medium was changed to OPTIMEM 1 (GIBCO), 0.5 mL/well. Two 
luciferase plasmids, firefly luciferase (pGL2) and Renilla luciferase (pRL-CMV)  from 
Promega, were used as reporter and control, respectively. Co-transfection of 
plasmids and siRNAs was carried out with Lipofectamine 2000 (Invitrogen) as 
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described by the manufacturer for adherent cell lines. Per well, 1.0 μg pGL2, 0.1 μg 
pRL-CMV and the required amount of siRNAs, formulated into liposomes, were 
applied. The final volume was 500 μL per well. The cells were harvested 24 h after 
transfection, and lysed by using passive lysis buffer (PLB), 100 μL per well, 
according to the instructions of the Dual-Luciferase Reporter Assay System 
(Promega, USA). The luciferase activities of the samples were measured using a 
MicroLumaPlus LB 96V (Berthold Technologies) with a delay time of 2 s and an 
integrate time of 10 s. The volumes used were: 20 μL of sample and 30 μL of each 
reagent (luciferase assay reagent II and Stop & Glo Reagent). The inhibitory effects 
generated by siRNAs were expressed as normalized ratios between the activities of 
the reporter GL2 (Photinus pylaris) luciferase gene and the control RL (Renilla 
reniformis) luciferase gene. 
 
Autodock-vina docking.2 
 
The protein (PDB: 1si3) and the ligands (pyrene, anthracene, naphthalene, 
trifluoromethyl benzene and fluorobenzene) were prepared for the docking using 
autodock tools (ADT).3 The following parameters were employed in the docking: 
Search Space: 
Center:_x = 16.837.  
Center_y = 77.117.  
Center_z: –13.227. 
Size_x: 12 angstroms. 
Size_y: 12 angstroms. 
Size_z: 12 angstroms. 
Exhaustiveness: 300. 
 
                                                 
2
  O. Trott, A. J. Olson J. Comput. Chem. 2009, DOI: 10.1002/jcc.21334. 
3
  M. F. Sanner. J. Mol Graphics Mod. 1999, 17, 57-61. 
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